中华肝脏病杂志
中華肝髒病雜誌
중화간장병잡지
CHINESE JOURNAL OF HEPATOLOGY
2010年
2期
92-95
,共4页
李晓光%胥婕%刘宝明%杨靖娴%闫玲%李彤%庄辉
李曉光%胥婕%劉寶明%楊靖嫻%閆玲%李彤%莊輝
리효광%서첩%류보명%양정한%염령%리동%장휘
肝炎,乙型,慢性%肝炎病毒,乙型%变异(遗传学)%抗药性%基因型%血清分型
肝炎,乙型,慢性%肝炎病毒,乙型%變異(遺傳學)%抗藥性%基因型%血清分型
간염,을형,만성%간염병독,을형%변이(유전학)%항약성%기인형%혈청분형
Hepatitis B,chronic%Hepatitis B virus%Variation (genetics)%Drug resistance%Genotype%Serotyping
目的 研究未经核苷(酸)类似物(NA)治疗的慢性乙型肝炎患者HBV耐药变异、基因型、基因亚型和血清型特点.方法 从北京大学附属医院收集97例未经NA治疗的慢性乙型肝炎患者血清,用半巢式聚合酶链反应-直接测序法获得HBV全长逆转录酶区序列,用生物信息学技术筛查该区内11个经典耐药变异位点并鉴定基因型、基因亚型和血清型.用统计分析软件SPSS11.0进行t检验和χ~2检验. 结果 HBV在11个经典耐药变异位点上均为野生型氨基酸;B基因型和C基因型分别占36.1%(35/97)和63.9%(62/97),前者均属B2亚型,后者C2亚型占91.9%(57/62),C1亚型占6.5%(4/62),1例未能分出亚型.已知出生地的患者中,71.9%(23/32) B基因型感染者出生于我国南方地区,81.6%(40/49) C基因型感染者出生于北方地区,基因型地域分布特点明显,χ~2=23.19,P<0.01.血清型为adr者占60.8%(59/97),与C基因型相关;为adw者占38.1%(37/97),与B基因型相关,χ~2=87.83,P<0.01.结论 未经NA治疗的慢性乙型肝炎患者体内野毒株为优势株,其基因型、基因亚型和血清型与患者出生地有关.
目的 研究未經覈苷(痠)類似物(NA)治療的慢性乙型肝炎患者HBV耐藥變異、基因型、基因亞型和血清型特點.方法 從北京大學附屬醫院收集97例未經NA治療的慢性乙型肝炎患者血清,用半巢式聚閤酶鏈反應-直接測序法穫得HBV全長逆轉錄酶區序列,用生物信息學技術篩查該區內11箇經典耐藥變異位點併鑒定基因型、基因亞型和血清型.用統計分析軟件SPSS11.0進行t檢驗和χ~2檢驗. 結果 HBV在11箇經典耐藥變異位點上均為野生型氨基痠;B基因型和C基因型分彆佔36.1%(35/97)和63.9%(62/97),前者均屬B2亞型,後者C2亞型佔91.9%(57/62),C1亞型佔6.5%(4/62),1例未能分齣亞型.已知齣生地的患者中,71.9%(23/32) B基因型感染者齣生于我國南方地區,81.6%(40/49) C基因型感染者齣生于北方地區,基因型地域分佈特點明顯,χ~2=23.19,P<0.01.血清型為adr者佔60.8%(59/97),與C基因型相關;為adw者佔38.1%(37/97),與B基因型相關,χ~2=87.83,P<0.01.結論 未經NA治療的慢性乙型肝炎患者體內野毒株為優勢株,其基因型、基因亞型和血清型與患者齣生地有關.
목적 연구미경핵감(산)유사물(NA)치료적만성을형간염환자HBV내약변이、기인형、기인아형화혈청형특점.방법 종북경대학부속의원수집97례미경NA치료적만성을형간염환자혈청,용반소식취합매련반응-직접측서법획득HBV전장역전록매구서렬,용생물신식학기술사사해구내11개경전내약변이위점병감정기인형、기인아형화혈청형.용통계분석연건SPSS11.0진행t검험화χ~2검험. 결과 HBV재11개경전내약변이위점상균위야생형안기산;B기인형화C기인형분별점36.1%(35/97)화63.9%(62/97),전자균속B2아형,후자C2아형점91.9%(57/62),C1아형점6.5%(4/62),1례미능분출아형.이지출생지적환자중,71.9%(23/32) B기인형감염자출생우아국남방지구,81.6%(40/49) C기인형감염자출생우북방지구,기인형지역분포특점명현,χ~2=23.19,P<0.01.혈청형위adr자점60.8%(59/97),여C기인형상관;위adw자점38.1%(37/97),여B기인형상관,χ~2=87.83,P<0.01.결론 미경NA치료적만성을형간염환자체내야독주위우세주,기기인형、기인아형화혈청형여환자출생지유관.
Objective To investigate drug resistance, ganotype and serotype of hepatitis B virus (HBV) in nucleos(t)ide analogue (NA) naive patients with chronic hepatitis B (CHB). Methods Full-length reverse transcriptase region of HBV DNA was amplified by semi-nested polymerase chain reaction from 97 NA-naive CHB patients, and the PCR product was sequenced, and analyzed to screen 11 classical antiviral drug resistance mutation sites and to identify HBV genotypes, subgenotypes and serotypes. Results Wild-type sequences were found at all of the 11 classical antiviral drug resistance mutation sites from all samples. The patients were infected with either genotype B (36.1%, 35/97) or C (63.9%, 62/97) HBV. The former were all belonged to subgenotype B2 strain;while the latter were divided further into subgenotype C2 (91.9%, 57/62), subgenotype C1 (6.5%, 4/62) and unknown subgenotype (1.6%, 1/62). The 71.9% (23/32) of HBV genotype B patients were born in southern China, while 81.6% (40/49) of HBV genotype C patients were from northem China, showing a clear geographic distribution ( χ~2 = 23.19, P < 0.01). Of 97 CHB patients, 59 (60.8%) were serotype adr associated with genotype C, while 37 (38.1%) were adw related to genotype B (subgenotype B2) (χ~2= 87.83, P < 0.01). Conclusion The wild-type HBV strains prevail in NA-naive CHB patients, whose HBV genotypes, subgenotypes and serotypes are associated with their places of birth.